APA

Latorre M., Novelli F., Vagaggini B., Braido F., Papi A., Sanduzzi A., Santus P., Scichilone N. & Paggiaro P. (20151103). Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS. : Pulmonary pharmacology & therapeutics.

Chicago

Latorre M, Novelli F, Vagaggini B, Braido F, Papi A, Sanduzzi A, Santus P, Scichilone N and Paggiaro P. 20151103. Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS. : Pulmonary pharmacology & therapeutics.

Harvard

Latorre M., Novelli F., Vagaggini B., Braido F., Papi A., Sanduzzi A., Santus P., Scichilone N. and Paggiaro P. (20151103). Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS. : Pulmonary pharmacology & therapeutics.

MLA

Latorre M, Novelli F, Vagaggini B, Braido F, Papi A, Sanduzzi A, Santus P, Scichilone N and Paggiaro P. Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS. : Pulmonary pharmacology & therapeutics. 20151103.